Vistagen Therapeutics Inc (VTGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2015 | 03-2014 | 03-2013 | 03-2012 | 03-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -13,886 | -2,968 | -12,887 | -12,210 | -9,482 |
| Depreciation Amortization | 3,417 | 695 | 289 | 1,022 | 2,051 |
| Accounts receivable | N/A | N/A | 106 | -64 | 205 |
| Other Working Capital | 2,132 | 2,305 | 1,624 | 615 | 5,165 |
| Other Operating Activity | 5,569 | -2,158 | 7,404 | 7,071 | 1,220 |
| Operating Cash Flow | $-2,769 | $-2,126 | $-3,463 | $-3,566 | $-841 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -10 | -135 | -32 | -58 |
| Investing Cash Flow | $N/A | $-10 | $-135 | $-32 | $-58 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 800 |
| Debt Issued | N/A | 250 | 3,222 | 467 | 270 |
| Debt Repayment | -308 | -156 | -514 | -772 | -233 |
| Common Stock Issued | 3,147 | 1,340 | 1,447 | 3,846 | N/A |
| Other Financing Activity | 0 | 64 | 0 | 0 | 0 |
| Financing Cash Flow | $2,839 | $1,498 | $4,156 | $3,540 | $837 |
| Beginning Cash Position | N/A | 638 | 81 | 139 | 201 |
| End Cash Position | 70 | N/A | 638 | 81 | 139 |
| Net Cash Flow | $70 | $-638 | $557 | $-58 | $-62 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,769 | -2,126 | -3,463 | -3,566 | -841 |
| Capital Expenditure | N/A | -10 | -135 | -32 | -58 |
| Free Cash Flow | -2,769 | -2,136 | -3,599 | -3,598 | -899 |